Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
Alexandria May, PharmD, BCPS
Kaitlin Batley, MD
Tardive Dyskinesia, Decoded: From Subtle Signs to Personalized VMAT2 Therapy
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
VMAT2 in the Real World: Recently Presented PRO Data That Should Change TD Practice
Closing the Gap: Equity, Disparities, and Access to TD Diagnosis and Care
When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
Treating the Complex Patient: TD Management in Older Adults and Medically Fragile Populations
The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
FXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
Understanding Variability in Myasthenia Gravis
Henry Kaminski, MD
Examining the Global Genetic Prevalence of TK2d
Brian P. McDonough, MD, FAAFP
Austin Larson, MD
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
Ryan Quigley
MS in Women: How Life Stages Shape Treatment Decisions
Unpacking the Genetics of Friedreich’s Ataxia
Arnulf Koeppen, MD
Is Friedreich’s Ataxia Developmental or Degenerative?
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.